Li JN - Search Results

1

The study of influence factors on (131)I treatment of differentiated thyroid carcinoma with lymph node metastases.

Ye ZY, Wang H, Fu HL, Li JN, Zou RJ, Gu ZH, Wu JC. Ye ZY, et al. Among authors: li jn. Clin Imaging. 2009 May-Jun;33(3):221-5. doi: 10.1016/j.clinimag.2008.09.006. Clin Imaging. 2009. PMID: 19411029

2

Dedifferentiation of differentiated thyroid carcinoma cell line FTC-133 is enhanced by 131I pretreatment.

Feng F, Wang H, Fu H, Wu S, Ye Z, Chen S, Li J. Feng F, et al. Nucl Med Biol. 2011 Oct;38(7):1053-8. doi: 10.1016/j.nucmedbio.2011.03.001. Epub 2011 Apr 21. Nucl Med Biol. 2011. PMID: 21982575

3

Low- or high-dose radioiodine remnant ablation for differentiated thyroid carcinoma: a meta-analysis.

Cheng W, Ma C, Fu H, Li J, Chen S, Wu S, Wang H. Cheng W, et al. J Clin Endocrinol Metab. 2013 Apr;98(4):1353-60. doi: 10.1210/jc.2012-3682. Epub 2013 Feb 22. J Clin Endocrinol Metab. 2013. PMID: 23436920

4

The efficacy of radioiodine remnant ablation for differentiated thyroid carcinoma patients with an incomplete thyroidectomy.

Hfu H, Ma C, Li J, Feng F, Wu S, Ye Z, Wang H. Hfu H, et al. Q J Nucl Med Mol Imaging. 2016 Sep;60(3):280-4. Epub 2014 Sep 5. Q J Nucl Med Mol Imaging. 2016. PMID: 25192307

5

The role of single-photon emission computed tomography/computed tomography for precise localization of metastases in patients with differentiated thyroid cancer.

Wang H, Fu HL, Li JN, Zou RJ, Gu ZH, Wu JC. Wang H, et al. Among authors: li jn. Clin Imaging. 2009 Jan-Feb;33(1):49-54. doi: 10.1016/j.clinimag.2008.06.024. Clin Imaging. 2009. PMID: 19135930

6

Comparison of whole-body 18F-FDG SPECT and posttherapeutic 131I scintigraphy in the detection of metastatic thyroid cancer.

Wang H, Fu HL, Li JN, Zhou RJ, Hui Gu Z, Wu JC, Huang G. Wang H, et al. Among authors: li jn. Clin Imaging. 2008 Jan-Feb;32(1):32-7. doi: 10.1016/j.clinimag.2007.07.010. Clin Imaging. 2008. PMID: 18164392

7

Efficacy of lentiviral-mediated transfection of hTSHR in poorly differentiated thyroid carcinoma cell line.

Cheng W, Fu H, Feng F, Ma C, Li J, Chen S, Wang H. Cheng W, et al. Nucl Med Biol. 2013 May;40(4):576-80. doi: 10.1016/j.nucmedbio.2012.12.004. Nucl Med Biol. 2013. PMID: 23618770

8

rhTSH-aided low-activity versus high-activity regimens of radioiodine in residual ablation for differentiated thyroid cancer: a meta-analysis.

Ma C, Tang L, Fu H, Li J, Wang H. Ma C, et al. Nucl Med Commun. 2013 Dec;34(12):1150-6. doi: 10.1097/MNM.0b013e328365ac05. Nucl Med Commun. 2013. PMID: 24025918 Free PMC article. Review.

9

Use of 18F-FDG-PET-CT for Assessment of Response to Neoadjuvant Chemotherapy in Children With Wilms Tumor.

Qin Z, Tang Y, Wang H, Cai W, Fu H, Li J, Ma C. Qin Z, et al. J Pediatr Hematol Oncol. 2015 Jul;37(5):396-401. doi: 10.1097/MPH.0000000000000323. J Pediatr Hematol Oncol. 2015. PMID: 25749587

10

Evaluation of radionuclide cerebrospinal fluid scintigraphy as a guide in the management of patients with hydrocephalus.

Feng F, Fu HL, Li JN, Zhou RJ, Gui ZH, Wu JC, Wang H. Feng F, et al. Among authors: li jn. Clin Imaging. 2009 Mar-Apr;33(2):85-9. doi: 10.1016/j.clinimag.2008.06.033. Clin Imaging. 2009. PMID: 19237049

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

542 results

Search Page

Filters